Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Earth Science Tech Inc ETST

Healthcare
Earth Science Tech, Inc. is a holding company in the compounding pharmaceuticals and telemedicine sectors, through its wholly owned subsidiaries, RxCompoundStore.com, LLC. (RxCompound), Peaks Curative, LLC. (Peaks), and Earth Science Foundation, Inc. (ESF). RxCompound is a complete compounding pharmacy. RxCompound is licensed to fulfill prescriptions in the states of Florida, New York, New... see more

Recent & Breaking News (OTCPK:ETST)

Earth Science Tech: Another Marijuana Stock That Looks 'Insanely Overvalued'

Benzinga.com  February 10, 2017

Earth Science Tech Strengthens Advisory Board with Four Distinguished Scientists and Doctors to Expand the Pharmaceutical & Nutraceutical Development of Cannabinoids' Therapeutic Indications, R&D, Technology, IP and Treatments

GlobeNewswire February 9, 2017

Earth Science Tech Announces New Wholly Owned Subsidiary, Cannabis Therapeutics Inc., to Develop & Launch its Cannabis Cannabinoid-Based Drugs & Nutraceuticals Using its Cannabinoid-Cannabidiol (CBD) Patent, IP and Technology

GlobeNewswire February 6, 2017

Earth Science Tech, Enters Multi-Billion Dollar Sports Supplement Industry via Joint Venture with Nutrition Specialties and Forzagen

GlobeNewswire January 31, 2017

Earth Science Tech, Inc. (OTC: ETST) Finalizes Joint Venture with Karmavore Superfoods and Signs New CMO, Sergio Castillo

GlobeNewswire January 25, 2017

Earth Science Tech, Inc. (OTC: ETST) Signs Marketing & Media Agreement with Pearls of Health and Appoints Gabriel Aviles as Chief Sales Officer (CSO).

GlobeNewswire January 9, 2017

Earth Science Tech Engages RedChip to Lead Investor Relations Efforts 

GlobeNewswire December 28, 2016

Earth Science Tech Announces the Development of 3 New Advanced Formulated Cannabis CBD Nutraceuticals and 2 Cannabis CBD-Based Pharmaceutical Drugs under its Cannabis CBD Patent, IP and Technology

GlobeNewswire December 20, 2016

ETST Announces 60-Patient Clinical Prelaunch Study for its MSN-2 Medical Device for the Diagnosis of Chlamydia & Gonorrhea, ETST Elects Dr. Michel Aubé as New CEO & CSO, and Nickolas Tabraue as President.

GlobeNewswire November 21, 2016

ETST Announces cGMP Certification and Bottling for its Scientific High-Grade Hemp Cannabidiol (CBD) Products as well as New Labeling & Packaging Due to Increase International Demand

GlobeNewswire November 1, 2016

ETST Acquires the Assets and Business of BEO-ITS, Inc., a Canadian Biotech Company Specializing in Medical Devices, Tests and Vaccines for Sexually Transmitted Infections and/or Diseases

GlobeNewswire August 24, 2016

ETST Announces the Execution of a Binding LOI to Acquire 100% of the Assets of a Canadian Biotech Company Specializing in Medical Devices, Testing and Vaccines and Forms New Wholly Owned Subsidiary, Earth Science Pharmaceutical, Inc.

GlobeNewswire June 20, 2016